Abstract
In this issue of Chemistry & Biology, Schust et al. [1] report the discovery of a small molecule (Stattic) that inhibits the binding of a high affinity phosphopeptide for the SH2 domain of Stat3. Stattic is a new tool for studying Stat3 signaling and demonstrates that the SH2 domain is not a dead target.
Original language | English (US) |
---|---|
Pages (from-to) | 1123-1124 |
Number of pages | 2 |
Journal | Chemistry and Biology |
Volume | 13 |
Issue number | 11 |
DOIs | |
State | Published - Nov 2006 |
ASJC Scopus subject areas
- Biochemistry
- Molecular Medicine
- Molecular Biology
- Pharmacology
- Drug Discovery
- Clinical Biochemistry